Navalign LLC’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Navalign LLC's ABBV Position: Q2 2026 in Review
Navalign LLC reduced its AbbVie (ABBV) stake by 0.3% in Q2 2026, selling an estimated $1.51K and leaving 2,344 shares worth $590K. The position accounts for 0.14% of the portfolio, ranked #87.
Navalign LLC first reported a position in ABBV in Q1 2021 and has held it in 22 quarters since. The position peaked at $611K in Q3 2025. 2,841 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Navalign LLC held 2,344 shares of AbbVie worth $590K as of Q2 2026.
- Navalign LLC sold 7 AbbVie shares in Q2 2026, an estimated $1.51K.
- AbbVie made up 0.14% of Navalign LLC's portfolio in Q2 2026, its #87 holding.
- Navalign LLC first reported a position in AbbVie in Q1 2021 and has held it in 22 quarters since.
- Navalign LLC's AbbVie position peaked at $611K in Q3 2025.
- 2,841 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Navalign LLC's 13F filing for Q2 2026, filed 28 Jul 2026.